The effect of the trichloroethylene metabolites trichloroacetate and dichloroacetate on peroxisome proliferation and DNA synthesis in cultured human hepatocytes

Cell Biology and Toxicology

Volumn 16, Issue 4, 2000, Pages 257-273

  Walgren, J E ^a   Kurtz, D T ^a   Mcmillan, J M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell proliferation; Dichloroacetate; Human hepatocytes; Peroxisome proliferation; Trichloroacetate; Trichloroethylene

Indexed keywords

CARCINOGEN; CYTOCHROME P450; DICHLOROACETIC ACID; DNA; PALMITOYL COENZYME A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PIRINIXIC ACID; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CULTURE; METABOLITE; PRIORITY JOURNAL; TOXICOKINETICS;

ANIMALS; CELL DIVISION; CELLS, CULTURED; DICHLOROACETATE; DNA; HEPATOCYTES; HUMANS; LIVER; MICE; PALMITOYL COENZYME A; PEROXISOME PROLIFERATORS; PEROXISOMES; PYRIMIDINES; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

RODENTIA;

EID: 0033773932     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007638227821     Document Type: Article

References (63)

1. Cancer incidence among Finnish workers exposed to halogenated hydrocarbons
2. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk
3. Delayed effects of ciprofibrate on rat liver peroxisomal properties and proto-oncogene expression
4. Hepatic peroxisome proliferation in rodents and its significance for humans
5. The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey, and human hepatocytes
6. Influence of fenofibrate on cellular and subcellular structure in hyperlipidemic patients
7. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: A dose-effect study
8. 1 mice by dichloroacetate
9. The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene
10. Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators
11. Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver
12. 1 mouse
13. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat
14. 1 mice
15. Trichloroacetate stimulation of liver DNA synthesis in male and female mice
16. Absorption, elimination, and metabolism of trichloroethylene: A quantitative comparison between mice and rats
17. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment
18. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14,643 to clofibric acid, nafenopin and LY171883
19. Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: A biochemical human hazard assessment
20. Peroxisome proliferation due to di(2-ethyhexyl)phthalate: Species differences and possible mechanisms
21. Dichloroacetic acid induction of peroxisome proliferation in cultured hepatocytes
22. Morphometric study of human hepatic cell modifications induced by fenofibrate
23. Effects of the hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver
24. A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity
25. The establishment and continuous subculturing of normal human adult hepatocytes: Expression of differentiated liver functions
26. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures
27. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activated receptor α
28. Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: A case-control study
29. The peroxisome proliferator nafenopin does not suppress hepatocyte apoptosis in guinea pig liver in vivo nor in human hepatocytes in vitro
30. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney
31. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver
32. A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?
33. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis
34. Induction of replicative DNA synthesis and PPARα-dependent gene transcription by Wy-14,643 in primary rat hepatocyte and non-parenchymal cell co-cultures
35. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously
36. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
37. Assay of peroxisomal beta-oxidation of fatty acids
38. Activation of immediate-early gene expression by peroxisome proliferators in vitro
39. 1 mice
40. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643) in rats
41. Liver regeneration: Molecular mechanisms of growth control
42. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydrolase, by clofibric acid
43. Peroxisome proliferator activated receptor-alpha expression in human liver
44. Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters
45. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
46. 1 mice
47. Rodent hepatocarcinogenic peroxisome proliferators induce proliferation of rat hepatocytes in primary mixed cultures with rat liver epithelial cells
48. Effect of hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes
49. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: Glucocorticoid-induced PPARα is linked to peroxisome proliferator mitogenesis
50. Oxidative DNA damage caused by persistent peroxisome proliferation: Its role in hepatocarcinogenesis
51. Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fischer (F344) rats
52. Dose-dependent metabolism of trichloroethylene and its relevance to hepatotoxicity in rats
53. Measurement of protein using bicinchoninic acid
54. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results
55. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetic acid (DCA) and trichloroacetic acid (TCA)
56. Trichloroacetic acid: Studies on uptake and effects on hepatic DNA and liver growth in mouse
57. Chlorinated acids and chloral in drinking water
58. The peroxisome proliferator (PP) response element upstream of the human acyl-CoA oxidase gene is inactive among a sample human population: Significance for species differences in response to PP's
59. Final report: Historical prospective mortality study of aircraft employees at Air Force plant No. 44 Almeda, CA (USA)
60. Peroxisome proliferator-activated receptors (PPARs) and carcinogenesis